NICE nixes Novartis asthma med for young kids; Stada sales suffer on European … – FiercePharma

NICE nixes Novartis asthma med for young kids; Stada sales suffer on European
FiercePharma
NICE has refused to back the use of Novartis' Xolair for young children, saying the asthma drug's cost brings little extra benefits over existing treatments

and more »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *